Informa plc (LON:INF – Get Free Report) has been given a consensus recommendation of “Moderate Buy” by the seven research firms that are currently covering the firm, MarketBeat Ratings reports. One analyst has rated the stock with a hold recommendation and six have assigned a buy recommendation to the company. The average 1 year price target among brokerages that have covered the stock in the last year is GBX 1,097.86.
Several equities research analysts have recently commented on INF shares. Deutsche Bank Aktiengesellschaft boosted their price objective on Informa from GBX 1,000 to GBX 1,140 and gave the company a “buy” rating in a report on Wednesday, October 29th. UBS Group reissued a “buy” rating and issued a GBX 1,055 price target on shares of Informa in a research report on Friday, November 7th. Panmure Gordon restated a “buy” rating and set a GBX 1,200 price objective on shares of Informa in a report on Wednesday, November 19th. Citigroup lifted their price objective on shares of Informa from GBX 975 to GBX 1,000 and gave the company a “neutral” rating in a report on Thursday, January 22nd. Finally, JPMorgan Chase & Co. lowered their target price on shares of Informa from GBX 1,345 to GBX 1,330 and set an “overweight” rating on the stock in a report on Monday, January 12th.
Insider Buying and Selling at Informa
Informa Stock Performance
Shares of Informa stock opened at GBX 845.20 on Friday. The business has a 50-day simple moving average of GBX 890.83 and a 200 day simple moving average of GBX 905.27. Informa has a one year low of GBX 634.20 and a one year high of GBX 1,000. The company has a debt-to-equity ratio of 31.98, a current ratio of 0.56 and a quick ratio of 1.70. The firm has a market capitalization of £10.80 billion, a price-to-earnings ratio of 153.67, a PEG ratio of 0.75 and a beta of 1.12.
About Informa
Our events, digital products and academic research services connect specialists with knowledge, helping them learn more, know more and do more.
We do this in dozens of specialist markets and subject matter categories, including in Healthcare & Pharma, Technology, Finance, Education, Marketing, Health & Nutrition, Foodservice, and many more.
And we do this through a range of products and services, including major live events, specialist media and content, expert research articles, books and open research platforms, accredited training, buyer discovery services, and digital demand and lead-generation services.
Read More
- Five stocks we like better than Informa
- Nvidia CEO Issues Bold Tesla Call
- Your Bank Account Is No Longer Safe
- Buy this Gold Stock Before May 2026
- What a Former CIA Agent Knows About the Coming Collapse
- The day the gold market broke
Receive News & Ratings for Informa Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Informa and related companies with MarketBeat.com's FREE daily email newsletter.
